Clever Leaves Holdings Inc banner

Clever Leaves Holdings Inc
OTC:CLVR

Watchlist Manager
Clever Leaves Holdings Inc Logo
Clever Leaves Holdings Inc
OTC:CLVR
Watchlist
Price: 0.0006 USD Market Closed
Market Cap: $1.1k

EV/EBITDA

0.5
Current
39%
More Expensive
vs 3-y average of 0.3

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
0.5
=
Enterprise Value
$-6.1m
/
EBITDA
$-13.2m

Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.

EV/EBITDA
0.5
=
Enterprise Value
$-6.1m
/
EBITDA
$-13.2m

Valuation Scenarios

Clever Leaves Holdings Inc is trading above its 3-year average

If EV/EBITDA returns to its 3-Year Average (0.3), the stock would be worth $0 (28% downside from current price).

Statistics
Positive Scenarios
1/2
Maximum Downside
-28%
Maximum Upside
+3 118 580%
Average Upside
1 559 276%
Scenario EV/EBITDA Value Implied Price Upside/Downside
Current Multiple 0.5 $0
0%
3-Year Average 0.3 $0
-28%
Country Average 14 413.7 $18.71
+3 118 580%

Forward EV/EBITDA
Today’s price vs future ebitda

Today's Enterprise Value EBITDA Forward EV/EBITDA
$-6.1m
/
Jan 2024
$-13.2m
=
0.5
Current
$-6.1m
/
Dec 2024
$-5.1m
=
1.2
Forward
$-6.1m
/
Dec 2025
$25.5m
=
-0.2
Forward

Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.

Peer Comparison

All Multiples
EV/EBITDA
P/E
All Countries
Close
Market Cap EV/EBITDA P/E
CO
Clever Leaves Holdings Inc
OTC:CLVR
1k USD 0.5 -0
US
Eli Lilly and Co
NYSE:LLY
853.2B USD 28 41.3
US
Johnson & Johnson
NYSE:JNJ
544.6B USD 16.6 25.9
CH
Roche Holding AG
SIX:ROG
248.4B CHF 11.6 19.6
UK
AstraZeneca PLC
LSE:AZN
225.8B GBP 16.2 29.3
CH
Novartis AG
SIX:NOVN
222.8B CHF 12.4 20
US
Merck & Co Inc
NYSE:MRK
278.5B USD 9.5 15.3
IE
Endo International PLC
LSE:0Y5F
244.4B USD 386.8 -83.6
DK
Novo Nordisk A/S
CSE:NOVO B
1.1T DKK 8 10.9
US
Pfizer Inc
NYSE:PFE
155.3B USD 7.7 20
US
Bristol-Myers Squibb Co
NYSE:BMY
119.6B USD 7.2 17
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average EV/EBITDA: 45.9
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
28
21%
1.3
US
Johnson & Johnson
NYSE:JNJ
16.6
8%
2.1
CH
Roche Holding AG
SIX:ROG
11.6
6%
1.9
UK
AstraZeneca PLC
LSE:AZN
16.2
12%
1.4
CH
Novartis AG
SIX:NOVN
12.4
5%
2.5
US
Merck & Co Inc
NYSE:MRK
9.5
4%
2.4
IE
E
Endo International PLC
LSE:0Y5F
386.8
N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
8
2%
4
US
Pfizer Inc
NYSE:PFE
7.7
-8%
N/A
US
Bristol-Myers Squibb Co
NYSE:BMY
7.2
-10%
N/A
P/E Multiple
Earnings Growth PEG
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average P/E: 22.1
Negative Multiple: -0
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
41.3
32%
1.3
US
Johnson & Johnson
NYSE:JNJ
25.9
8%
3.2
CH
Roche Holding AG
SIX:ROG
19.6
14%
1.4
UK
AstraZeneca PLC
LSE:AZN
29.3
25%
1.2
CH
Novartis AG
SIX:NOVN
20
14%
1.4
US
Merck & Co Inc
NYSE:MRK
15.3
14%
1.1
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -83.6 N/A N/A
DK
Novo Nordisk A/S
CSE:NOVO B
10.9
0%
N/A
US
Pfizer Inc
NYSE:PFE
20
22%
0.9
US
Bristol-Myers Squibb Co
NYSE:BMY
17
16%
1.1

Market Distribution

Lower than 100% of companies in Colombia
Percentile
0th
Based on 14 companies
0th percentile
0.5
Low
2.7 — 8.7
Typical Range
8.7 — 26 184.2
High
26 184.2 —
Distribution Statistics
Colombia
Min 2.7
30th Percentile 8.7
Median 14 413.7
70th Percentile 26 184.2
Max 326 289.4

Clever Leaves Holdings Inc
Glance View

Market Cap
1.1k USD
Industry
Pharmaceuticals

Clever Leaves Holdings Inc. is a leading player in the global cannabis industry, with a mission to provide high-quality, sustainable, and compliant cannabinoid products. Founded in 2018 and headquartered in New York, this vertically integrated company has established a robust operational presence in key markets, including Colombia, the United States, and Europe. Clever Leaves differentiates itself with a focus on international cultivation and distribution, leveraging Colombia's ideal climate for cannabis production, resulting in cost-effective and high-quality products. This strategic positioning allows the company to cater to a diverse customer base, from pharmaceutical companies to consumer brands, as it navigates the emerging global cannabinoid landscape. As an investor, you’ll find that Clever Leaves embodies the principles of responsible growth and innovation through its unwavering commitment to compliance and quality. With multiple certifications enabling it to trade in international markets, the company is well-prepared to capitalize on the evolving regulations surrounding cannabis. Their expansive research and development initiatives, along with solid supply chain management, aim to unlock new product opportunities, positioning Clever Leaves for potential long-term success in the burgeoning cannabinoid sector. As the global market continues to mature, Clever Leaves is poised to take advantage of expanding consumer demand for cannabis-derived products, making it an intriguing investment opportunity for those looking to enter this dynamic and rapidly growing industry.

CLVR Intrinsic Value
Not Available
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett